| Name | Title | Contact Details |
|---|
Enterin is pioneering the medical community`s understanding of the link between infections, dysfunction of the enteric nervous system (ENS) of the gut, and the early onset and chronic progression of neurodegenerative disease. We are leveraging years of research to become the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease. Our lead compound, ENT-01 (also known as kenterin), displaces membrane-bound alpha- synuclein (αS) aggregates from nerve cells in the ENS and improves neural signaling between the gut and the brain in preclinical models of Parkinson`s disease. In the gut, this results in improved motility. We are now progressing this drug through clinical trials in an attempt to reverse the constipation of Parkinson`s disease. Our long-term mission is to become the world leader in developing pharmaceutical therapies that repair the gut-brain axis.
Prospect Medical Holdings, Inc. is a leading provider of healthcare services comprised of 22 hospitals and over 140 primary and specialty care clinics located throughout Southern California, South Central Texas, Rhode Island, New Jersey, Connecticut, and Pennsylvania. Established in 1996, Prospect Medical Holdings, Inc. has grown into a significant provider of coordinated regional healthcare services throughout Southern California, South Central Texas, Rhode Island, New Jersey, Connecticut, and Pennsylvania. We were among the first healthcare providers in the country to adopt an operating model, termed Coordinated-Regional-Care, that prefigures the objectives of the Affordable Care Act – to improve quality, reduce cost and enhance overall patient care. Our comprehensive network aims to provide coordinated, personalized care. We specialize in building comprehensive networks of quality healthcare services designed to meet the needs of our patients and members. Our goal is always to ensure high-quality outcomes. Above all, we are committed to quality in all aspects of healthcare delivery, including: 1. Striving for the best possible patient outcomes 2. Maintaining the highest standards of patient safety 3. Acting with integrity at all times 4. Promoting open communication 5. Collaborating to better serve the healthcare needs of our communities
Transforming Behavioral Health Care with Data, Evidence and Insights. Owl Insights is the leading provider of precision-guided behavioral health (BH) care management technology.
Worldwide provider and innovator in the fields of wellness, beauty, rejuvenation and transformation across the globe at sea on cruise ships and on land.
Samaritan Regional Health System is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Samaritan Regional Health System is based in Ashland, OH. You can find more information on Samaritan Regional Health System at www.samaritanhospital.org